Evaluación de estrategias para la gestión de calidad en laboratorios clínicos: análisis de modo y efecto de fallo e indicador Budget Error
Revista Bioquímica y Patología Clínica · 28.12.2024 · 89 (1) · 33-43
DOI: 10.62073/qrh9yp04 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Bioquímica y Patología Clínica, online erschienen am 28.12.2024. Verfasst von José María Gimenez und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
In clinical laboratories, the precision and accuracy of results are crucial for medical decision- making, directly influencing patient safety. Implementing a quality management system ensures reliable results and improves healthcare.
Objectives
To evaluate the use of “Failure Mode and Effects Analysis” (FMEA) and the “Budget Error” (BE) indicator within the quality management system to improve quality and patient safety at the Laboratory of the Private University Hospital of Córdoba (HPUC), Argentina. Materials and Methods: Observational and analytical study at the HPUC Laboratory during 2021 and 2022, divided into two parts. The first part applied FMEA to categorize the risk of analytical methods and plan performance evaluation. The second part evaluated the BE to detect and correct errors in 11 selected analytes.
Results
In 2021, the FMEA determined a quarterly assessment for glucose, creatinine, bilirubin, ionogram, magnesium, and lactate. In 2022, 132 Total Error Index results were generated through RIQAS, identifying nine preventive actions and one corrective action based on the BE, compared to a single improvement detected by the proficiency testing.
Discussion
The integration of FMEA and the BE indicator, along with other quality tools, is essential to manage risk, optimize resources, and improve the performance of methods in clinical laboratories. This combination promotes proactive behavior, fosters a culture of quality, and facilitates continuous improvement in analytical practice.
Zitieren
APA
Gimenez, J. M., Bonetto, A., Abiega, C., & Lujan, P. R. (2024). Evaluación de estrategias para la gestión de calidad en laboratorios clínicos: análisis de modo y efecto de fallo e indicador Budget Error. Revista Bioquímica y Patología Clínica, 89(1), 33-43. https://doi.org/10.62073/qrh9yp04
Vancouver
Gimenez JM, Bonetto A, Abiega C, Lujan PR. Evaluación de estrategias para la gestión de calidad en laboratorios clínicos: análisis de modo y efecto de fallo e indicador Budget Error. Revista Bioquímica y Patología Clínica. 2024;89(1):33-43. doi:10.62073/qrh9yp04
BibTeX
@article{Gimenez2024,
author = {Gimenez, José María and Bonetto, Ayelén and Abiega, Claudio and Lujan, Pablo Rodrigo},
title = {Evaluación de estrategias para la gestión de calidad en laboratorios clínicos: análisis de modo y efecto de fallo e indicador Budget Error},
journal = {Revista Bioquímica y Patología Clínica},
year = {2024},
volume = {89},
number = {1},
pages = {33--43},
doi = {10.62073/qrh9yp04}
}
EUVIMED